Australia warns over doctors' fast-growing use of AI scribes

The Guardian reports that Australia's federal health department is warning about the rapid rise of AI scribes in healthcare. Briefing documents say the tools have little oversight, may route patient data overseas, and are often marketed as outside medical-device regulation. The department also raised concerns about inconsistent patient consent, possible Medicare cost effects, and the risk that LLM errors could affect clinical records.

Key details: A RACGP poll found GP use of AI scribes rose from 22% in August 2024 to 40% in November 2025, Australian officials warned about data security, consent, and regulatory gaps, The TGA is reviewing whether digital scribes need stronger oversight.

Why it matters: Ambient clinical AI is moving faster than consent and medical-device rules, making healthcare a live test of AI governance.